News

A team of researchers at University of California San Diego School of Medicine detail how GIV/Girdin, a ubiquitous signaling molecule plays a critical role in male fertility.

A novel artificial intelligence technology developed by researchers was able to detect over 90% of lung cancers in blood samples from nearly 800 individuals with and without cancer.

In a real-world trial, a team of clinician-researchers at Beth Israel Deaconess Medical Center have demonstrated that tests of self-collected saliva provided comparable results to tests performed by trained healthcare professionals using nasopharyngeal swabs.

Cardiovascular genetic testing in children presents unique challenges, requiring pre- and post-test counseling with an individualized approach for families, ideally with the involvement of a specialized interdisciplinary team, according to the American Heart Association.

Researchers have discovered a set of biomarkers that can be used to predict which patients diagnosed with glioblastoma may have tumors that are more resistant to radiation therapy. The discovery could inform treatment decisions that should enable patients to live longer.

In a new paper, researchers conducted a systematic review of the vitamin D and dietary intakes of members of the black community across the globe. The findings suggest that people of African descent should consider taking vitamin D supplements and consume more vitamin D rich foods.

Researchers from the University of Birmingham have confirmed the speed, accuracy and simplicity of a novel, highly sensitive testing method for COVID-19 that can be deployed at entertainment venues, airport arrival terminals, and in remote settings where clinical testing laboratories are not available.

A new electrochemical COVID-19 test has been developed by Penn researchers using electrodes made from graphite—the same material found in pencil lead. The electrodes reduce the cost to $1.50 per test and require only 6.5 minutes to deliver 100-pecent-accurate results from saliva samples and up to 88 percent accuracy in nasal samples.

Scientists at the NIH have developed a new sample preparation method to detect SARS-Cov-2. The method bypasses extraction of the virus’ genetic RNA material, simplifying sample purification and potentially reducing test time and cost.

Scientists have repurposed the genetic modification technology CRISPR to identify antibodies in patient blood samples in a move that could inspire a new class of medical diagnostics in addition to a host of other applications.